No headlines found.
No press releases found.
No news found.
The Fund seeks to provide, at the end of the current Outcome Period, returns that track the share price returns of the iShares MSCI EAFE ETF (the "Underlying ETF") that are in excess of the Spread in positive market environments, while providing downside protection with a Buffer against the first 15% of Underlying ETF losses. The stated Spread and Buffer are before Fund fees and expenses. The current Outcome Period is from April 1, 2026 to March 31, 2027. The Fund pursues a buffered strategy that seeks to provide returns that track the share price returns of the iShares MSCI EAFE ETF (the "Underlying ETF") (i.e., the market price returns of the Underlying ETF), at the end of a specified one-year period, from April 1 to March 31, as described below (the "Outcome Period"), subject to a "Spread," and to provide downside protection with a buffer against the first 15.00% of Underlying ETF losses for the Outcome Period (the "Buffer"). The Spread represents the opportunity cost (i.e., the upside performance a shareholder forgoes) in return for the downside protection provided by the Buffer. The Fund's intended return measured across different market conditions (e.g., rising or declining markets) is referred to as "outcomes".
Allianzim International Equity Buffer15 Uncapped Apr ETF trades on the BATS stock market under the symbol ARLI.
As of June 26, 2026, ARLI stock price was flat at $26.10 with 1 million shares trading.
ARLI has a market cap of $6.53 million. This is considered a Sub-Micro Cap stock.
ARLI support price is $25.92 and resistance is $26.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARLI shares will trade within this expected range on the day.
